Abortion Pill Risks Are 22 Times Higher Than FDA Claimed
A new study has found that the abortion pill mifepristone is significantly more dangerous than previously claimed by the Food and Drug Administration (FDA), with over one in 10 women experiencing serious complications after taking the drug.
The study, commissioned by the Foundation for the Restoration of America, examined data from 154,554 women who used the abortion pill in 2023. Researchers found that 11.2 percent, approximately 17,310 women, suffered a “serious adverse event” after taking the drug. These events can include things like hemorrhaging, the need for a blood transfusion, emergency room visits, or even sepsis.
“This drastic difference between the disclosed risk and the actual risk to patients undermines informed consent and endangers the lives of pregnant women,” researchers wrote, urging regulatory action in light of the findings.
The complication rate is about 22 times higher than the FDA’s previous estimate. In 2023, the FDA warned on its label for mifepristone that less than 0.5 percent of women suffered “serious adverse reactions” to the abortion pill.
“This is much different than the lie that women have been told that these drugs are safer than Tylenol,” said board-certified OB-GYN Dr. Christina Francis in comments to the Daily Wire.
The findings come amid a sharp rise in chemical abortions, which has surpassed 150,000 annually. Medication abortions made up 63 percent of all abortions in 2023.
The availability of abortion pills online has contributed to the increase. In early 2022, months before Roe v. Wade was overturned, the FDA removed a requirement for women to obtain abortion pills in person from a healthcare provider, allowing the drug to be obtained online through the mail.
